Wells Fargo & Company Abcam PLC Transaction History

Wells Fargo & Company

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$21.54 - $24.41 $147,979 - $167,696	6,870 Added 613.39%	7,990 $180,000
Q2 2023 Aug 15, 2023	SELL	$12.62 - $24.47 $5,742 - $11,133	-455 Reduced 28.89%	1,120 $27,000
Q1 2023 May 12, 2023	BUY	$12.98 - $17.1 $2,414 - $3,180	186 Added 13.39%	1,575 $21,000
Q4 2022 Feb 13, 2023	BUY	$13.92 - $17.0 $5,540 - $6,766	398 Added 40.16%	1,389 $21,000
Q3 2022 Nov 14, 2022	SELL	$13.36 - $16.75 $587 - $737	-44 Reduced 4.25%	991 $15,000
Q2 2022 Aug 12, 2022	SELL	$12.69 - $19.25 $456 - $693	-36 Reduced 3.36%	1,035 $15,000
Q1 2022 May 16, 2022	BUY	$15.5 - $23.89 $8,540 - $13,163	551 Added 105.96%	1,071 $19,000
Q4 2021 Feb 14, 2022	BUY	$20.04 - $23.84 $1,422 - $1,692	71 Added 15.81%	520 $12,000
Q3 2021 Nov 15, 2021	BUY	$17.38 - $21.54 $6,952 - $8,616	400 Added 816.33%	449 $9,000
Q1 2021 May 13, 2021	BUY	$19.22 - $24.3 $941 - $1,190	49 New	49 $1,000

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.